Real-World Outcomes

Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies.
Recent research suggests that 73% of patients with cancer do not discuss the cost of care with their care team.
Cancer patients receiving chemotherapy should have all their medications and herbal supplements reviewed by a pharmacist who specializes in cancer therapy, researchers say.
Hospital-based end-of-life care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient.
Perceptions of patients with cancer regarding secondary data use is essential to informing the implementation of oncology learning systems.
Pediatric organ transplant patients are at increased risk for many cancers, especially non-Hodgkin’s lymphoma - possibly due to Epstein-Barr viral transmission in the donor organ.